APA

van Capelle C. I., van der Beek N. A. M. E., Hagemans M. L. C., Arts W. F. M., Hop W. C. J., Lee P., Jaeken J., Frohn-Mulder I. M. E., Merkus P. J. F. M., Corzo D., Puga A. C., Reuser A. J. & van der Ploeg A. T. (20110307). Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. : Neuromuscular disorders : NMD.

Chicago

van Capelle C I, van der Beek N A M E, Hagemans M L C, Arts W F M, Hop W C J, Lee P, Jaeken J, Frohn-Mulder I M E, Merkus P J F M, Corzo D, Puga A C, Reuser A J and van der Ploeg A T. 20110307. Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. : Neuromuscular disorders : NMD.

Harvard

van Capelle C. I., van der Beek N. A. M. E., Hagemans M. L. C., Arts W. F. M., Hop W. C. J., Lee P., Jaeken J., Frohn-Mulder I. M. E., Merkus P. J. F. M., Corzo D., Puga A. C., Reuser A. J. and van der Ploeg A. T. (20110307). Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. : Neuromuscular disorders : NMD.

MLA

van Capelle C I, van der Beek N A M E, Hagemans M L C, Arts W F M, Hop W C J, Lee P, Jaeken J, Frohn-Mulder I M E, Merkus P J F M, Corzo D, Puga A C, Reuser A J and van der Ploeg A T. Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. : Neuromuscular disorders : NMD. 20110307.